Cross-talk between cardiac lymphatics and immune cells regulates inflammatory response and cardiac recovery after myocardial infarction

I tiakina i:
Ngā taipitopito rārangi puna kōrero
I whakaputaina i:Frontiers in Immunology vol. 16 (May 2025), p. 1557250-1557264
Kaituhi matua: Yang, Zhihua
Ētahi atu kaituhi: Zhang, Zeyu, Feng, Shaoling, Xujin Ning, Guo, Liuli, Du, Yijia, Wang, Shuai, Wang, Xianliang, Mao, Jingyuan
I whakaputaina:
Frontiers Media SA
Ngā marau:
Urunga tuihono:Citation/Abstract
Full Text
Full Text - PDF
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
Whakaahuatanga
Whakarāpopotonga:Myocardial infarction (MI) is a life-threatening disease with high morbidity and mortality, closely associated with immune-inflammatory responses. As essential pathways for immune cell clearance and interstitial fluid drainage, lymphatic vessels are critical in regulating tissue fluid homeostasis and systemic immune surveillance. Cardiac lymphatics interact with immune cells, directly and indirectly, to mediate post-MI inflammation, participate in the clearance of necrotic tissue, and contribute to cardiac remodeling. Studies indicate that after MI, promoting cardiac lymphangiogenesis can accelerate the clearance of infiltrated immune cells, reduce the production of pro-inflammatory cytokines, improve myocardial edema, mitigate inflammatory responses and fibrosis, and support recovery of cardiac function. Meanwhile, immune cells regulate the structure and function of cardiac lymphatics, influencing lymphangiogenesis and drainage efficiency. The interaction between cardiac lymphatics and immune cells is crucial for myocardial repair post-MI. This review first systematically summarizes the structure and function of cardiac lymphatics, then sorting the relationship between cardiac lymphatics and immune cells and their roles in myocardial repair after MI and finally proposes therapeutic strategies targeting the interaction between cardiac lymphatics and immune cells in MI treatment, to provide prospective insights for the prevention and treatment of MI in the future.
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1557250
Puna:Health & Medical Collection